Effect of TMS Treatment on Defense Mechanisms and Functionality in Patients With Depression

StatusNot Yet Recruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary endpoint removed 2 → 1 primary endpoints
See other at-risk trials from Namik Kemal University

Record History

See every version on ClinicalTrials.gov ↗

  1. Phase changed: not applicable → not specified Show 4 more changesShow less
    • Primary endpoint(s) modified
    • Interventions modified
    • Eligibility criteria revised
    • Secondary endpoints: 3 to 4
  2. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
This prospective observational study aims to evaluate changes in psychological defense mechanisms in patients with non-psychotic major depressive disorder (MDD) undergoing repetitive Transcranial Magnetic Stimulation (rTMS) therapy. The study investigates whether rTMS induces a shift from immature to more mature defense mechanisms and assesses how these changes relate to improvements in depressive symptom severity, anxiety levels, and overall functionality at baseline, 1-month, and 3-month follow-ups.
Trial Details
NCT Number NCT07853989
Lead Sponsor Namik Kemal University
Conditions
(from sponsor)		 Major Depressive Disorder (MDD)
Related terms Depression, Major Depressive Disorder
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov